301 related articles for article (PubMed ID: 26039671)
1. Discovery of Multitarget Antivirals Acting on Both the Dengue Virus NS5-NS3 Interaction and the Host Src/Fyn Kinases.
Vincetti P; Caporuscio F; Kaptein S; Gioiello A; Mancino V; Suzuki Y; Yamamoto N; Crespan E; Lossani A; Maga G; Rastelli G; Castagnolo D; Neyts J; Leyssen P; Costantino G; Radi M
J Med Chem; 2015 Jun; 58(12):4964-75. PubMed ID: 26039671
[TBL] [Abstract][Full Text] [Related]
2. The Transactions of NS3 and NS5 in Flaviviral RNA Replication.
Tay MYF; Vasudevan SG
Adv Exp Med Biol; 2018; 1062():147-163. PubMed ID: 29845531
[TBL] [Abstract][Full Text] [Related]
3. Structure-guided Discovery of a Novel Non-peptide Inhibitor of Dengue Virus NS2B-NS3 Protease.
Li L; Basavannacharya C; Chan KW; Shang L; Vasudevan SG; Yin Z
Chem Biol Drug Des; 2015 Sep; 86(3):255-64. PubMed ID: 25533891
[TBL] [Abstract][Full Text] [Related]
4. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target.
Lescar J; Luo D; Xu T; Sampath A; Lim SP; Canard B; Vasudevan SG
Antiviral Res; 2008 Nov; 80(2):94-101. PubMed ID: 18674567
[TBL] [Abstract][Full Text] [Related]
5. A Combined Genetic-Proteomic Approach Identifies Residues within Dengue Virus NS4B Critical for Interaction with NS3 and Viral Replication.
Chatel-Chaix L; Fischl W; Scaturro P; Cortese M; Kallis S; Bartenschlager M; Fischer B; Bartenschlager R
J Virol; 2015 Jul; 89(14):7170-86. PubMed ID: 25926641
[TBL] [Abstract][Full Text] [Related]
6. Computational screening of medicinal plant phytochemicals to discover potent pan-serotype inhibitors against dengue virus.
Tahir Ul Qamar M; Maryam A; Muneer I; Xing F; Ashfaq UA; Khan FA; Anwar F; Geesi MH; Khalid RR; Rauf SA; Siddiqi AR
Sci Rep; 2019 Feb; 9(1):1433. PubMed ID: 30723263
[TBL] [Abstract][Full Text] [Related]
7. Novel dengue virus NS2B/NS3 protease inhibitors.
Wu H; Bock S; Snitko M; Berger T; Weidner T; Holloway S; Kanitz M; Diederich WE; Steuber H; Walter C; Hofmann D; Weißbrich B; Spannaus R; Acosta EG; Bartenschlager R; Engels B; Schirmeister T; Bodem J
Antimicrob Agents Chemother; 2015 Feb; 59(2):1100-9. PubMed ID: 25487800
[TBL] [Abstract][Full Text] [Related]
8. Small-Molecule Inhibitor of Flaviviral NS3-NS5 Interaction with Broad-Spectrum Activity and Efficacy
Celegato M; Sturlese M; Vasconcelos Costa V; Trevisan M; Lallo Dias AS; Souza Passos IB; Queiroz-Junior CM; Messa L; Favaro A; Moro S; Teixeira MM; Loregian A; Mercorelli B
mBio; 2023 Feb; 14(1):e0309722. PubMed ID: 36622141
[TBL] [Abstract][Full Text] [Related]
9. Serotype-specific interactions among functional domains of dengue virus 2 nonstructural proteins (NS) 5 and NS3 are crucial for viral RNA replication.
Teramoto T; Balasubramanian A; Choi KH; Padmanabhan R
J Biol Chem; 2017 Jun; 292(23):9465-9479. PubMed ID: 28396347
[TBL] [Abstract][Full Text] [Related]
10. Discovery of antiviral molecules for dengue: In silico search and biological evaluation.
Cabarcas-Montalvo M; Maldonado-Rojas W; Montes-Grajales D; Bertel-Sevilla A; Wagner-Döbler I; Sztajer H; Reck M; Flechas-Alarcon M; Ocazionez R; Olivero-Verbel J
Eur J Med Chem; 2016 Mar; 110():87-97. PubMed ID: 26807547
[TBL] [Abstract][Full Text] [Related]
11. Diterpenes/Diterpenoids and Their Derivatives as Potential Bioactive Leads against Dengue Virus: A Computational and Network Pharmacology Study.
Khan RA; Hossain R; Siyadatpanah A; Al-Khafaji K; Khalipha ABR; Dey D; Asha UH; Biswas P; Saikat ASM; Chenari HA; Wilairatana P; Islam MT
Molecules; 2021 Nov; 26(22):. PubMed ID: 34833913
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies against dengue NS2B and NS3 proteins for the study of protein interactions in the flaviviral replication complex.
Moreland NJ; Tay MY; Lim E; Rathore AP; Lim AP; Hanson BJ; Vasudevan SG
J Virol Methods; 2012 Jan; 179(1):97-103. PubMed ID: 22040846
[TBL] [Abstract][Full Text] [Related]
13. Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin.
Tay MY; Fraser JE; Chan WK; Moreland NJ; Rathore AP; Wang C; Vasudevan SG; Jans DA
Antiviral Res; 2013 Sep; 99(3):301-6. PubMed ID: 23769930
[TBL] [Abstract][Full Text] [Related]
14. Two RNA Tunnel Inhibitors Bind in Highly Conserved Sites in Dengue Virus NS5 Polymerase: Structural and Functional Studies.
Arora R; Liew CW; Soh TS; Otoo DA; Seh CC; Yue K; Nilar S; Wang G; Yokokawa F; Noble CG; Chen YL; Shi PY; Lescar J; Smith TM; Benson TE; Lim SP
J Virol; 2020 Nov; 94(24):. PubMed ID: 32907977
[TBL] [Abstract][Full Text] [Related]
15. Looking for inhibitors of the dengue virus NS5 RNA-dependent RNA-polymerase using a molecular docking approach.
Galiano V; Garcia-Valtanen P; Micol V; Encinar JA
Drug Des Devel Ther; 2016; 10():3163-3181. PubMed ID: 27784988
[TBL] [Abstract][Full Text] [Related]
16. Construction of dengue virus protease expression plasmid and in vitro protease assay for screening antiviral inhibitors.
Lai H; Teramoto T; Padmanabhan R
Methods Mol Biol; 2014; 1138():345-60. PubMed ID: 24696347
[TBL] [Abstract][Full Text] [Related]
17. The C-terminal 50 amino acid residues of dengue NS3 protein are important for NS3-NS5 interaction and viral replication.
Tay MY; Saw WG; Zhao Y; Chan KW; Singh D; Chong Y; Forwood JK; Ooi EE; Grüber G; Lescar J; Luo D; Vasudevan SG
J Biol Chem; 2015 Jan; 290(4):2379-94. PubMed ID: 25488659
[TBL] [Abstract][Full Text] [Related]
18. Structure-based and ligand-based virtual screening of novel methyltransferase inhibitors of the dengue virus.
Lim SV; Rahman MB; Tejo BA
BMC Bioinformatics; 2011; 12 Suppl 13(Suppl 13):S24. PubMed ID: 22373153
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.
Takagi Y; Matsui K; Nobori H; Maeda H; Sato A; Kurosu T; Orba Y; Sawa H; Hattori K; Higashino K; Numata Y; Yoshida Y
Bioorg Med Chem Lett; 2017 Aug; 27(15):3586-3590. PubMed ID: 28539222
[TBL] [Abstract][Full Text] [Related]
20. Dengue Virus and Its Inhibitors: A Brief Review.
Tian YS; Zhou Y; Takagi T; Kameoka M; Kawashita N
Chem Pharm Bull (Tokyo); 2018; 66(3):191-206. PubMed ID: 29491253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
